" Procedure for producing a regioisomeric mixture of two derivatives of (11R, 17R) -11-epi-fistularin-3, inhibitory mixture of human leukemia cells "

Patent number:

ES2680044B2

Islas Canarias.svg
No items found.

Process for producing a regioisomeric mixture of two derivatives of (11R, 17R) -11-epi-fistularin-3, inhibitory mixture of human leukemia cells. The present invention relates to a specific extractive/synthetic process for obtaining a regioisomeric mixture of two derivatives of (11R, 17R) -11-epi-fistularin-3, from the biomass of the marine sponge Aplysina (= Verongia) Aerophobia, as well as its use in various therapies as inhibitors of human leukemia cells.

Countries:
Spain
Regions:
Canary Islands
Centers:
UNIVERSIDAD DE LAS PALMAS DE GRAN CANARIA
Other entities:
Sectors:
Health
Chemicals
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

La ventaja de este proceso para producir una mezcla regioisomérica de dos derivados de (11R, 17R) -11-epi-fistularina-3, mezcla inhibitoria de células de leucemia humana. La presente invención se refiere a un proceso extractivo/sintético específico para la obtención de una mezcla regioisomérica de dos derivados de (11R, 17R) -11-epi-fistularina-3, a partir de la biomasa de la esponja marina Aplysina (= Verongia) Aerofobia, así como su uso en diversas terapias como inhibidores de células leucémicas humanas. En el ámbito de aplicación comercial, compete al sector salud, sector farmacéutico.

Comments

Other related patents

Health

Diagnostic procedure for the determination of the Nox2 protein

Countries
Italy
Know more
Health

APOPTOTIC CELL STABILISATION COMPOUNDS

Countries
Spain
Know more
Health

STICK HANDLE FOR GALVANIC SKIN RESPONSE (GSR) AND TEMPERATURE MONITORING

Countries
Spain
Know more
Get back to patents directory